2000
DOI: 10.1111/j.1349-7006.2000.tb00922.x
|View full text |Cite
|
Sign up to set email alerts
|

Improved in vivo Antitumor Efficacy and Reduced Systemic Toxicity of Carboxymethylpullulan‐peptide‐doxorubicin Conjugates

Abstract: The antitumor efficacy of the conjugate of doxorubicin (DXR) and carboxymethylpullulan (CMPul) with Phe-Gly spacer (CMPul-FG-DXR) was evaluated using murine tumor models and compared with that of DXR. The conjugate exhibited higher antitumor efficacy against Lewis lung carcinoma than DXR.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 10 publications
0
4
0
Order By: Relevance
“…The intrinsic or acquired resistance of tumor cells to Dau also reduces the response to the treatment. Conjugation with different type of carrier (e.g., oligoand polypeptides, 1 proteins, 2 polysaccharides, 3 polymers, 4,5 dextran 6 ) could decrease the side-effects and improve the selectivity of the drug attached by utilization of different cellular uptake mechanism(s).…”
Section: Introductionmentioning
confidence: 99%
“…The intrinsic or acquired resistance of tumor cells to Dau also reduces the response to the treatment. Conjugation with different type of carrier (e.g., oligoand polypeptides, 1 proteins, 2 polysaccharides, 3 polymers, 4,5 dextran 6 ) could decrease the side-effects and improve the selectivity of the drug attached by utilization of different cellular uptake mechanism(s).…”
Section: Introductionmentioning
confidence: 99%
“…In the recent years, a large number of databases have been published, revealing discovery of novel peptides with therapeutic properties ranging from antimicrobial 2 3 4 , antimalarial 5 , antiparasitic 6 , anticancer 7 , cell penetrating 8 , tumor homing 9 , antihypertensive 10 etc. Peptides have gained leverage over antibody and small molecule-based drugs as they possess better tissue penetration, high specificity and comparatively low production cost 11 12 . Though hundreds of potential therapeutic peptides have been discovered so far, only limited peptide-based drugs are in the market.…”
mentioning
confidence: 99%
“…Compared to the free medication, the conjugation was more efficient at decreasing tumor volume and improving survival rates. The compound is solely effective against solid tumors (Nogusa et al., 2000a ). Pullulan exhibited excellent property in increasing the drug release at the tumor site for Epirubicin, Adriamycin, Doxorubicin, Methotrexate, and Combretastatin as mentioned in Table 3.…”
Section: Chemical Modification Of Pullulanmentioning
confidence: 99%